Schedule 13D ownership disclosure

THERAPIX BIOSCIENCES LTD

Security class unavailable · CUSIP: 88339A203

Event date: 2020-05-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
12.5800%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001213900-20-013951
Form type
SC 13D
Filer
L.I.A. Pure Capital Ltd
CIK
CIK 1749628
Filed
Jun 02, 2020
Reporting period
May 31, 2020
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub